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Background. The aim of this study was to evaluate the antiangiogenic response and its relation to
regeneration and angiogenesis after 70% hepatectomy in a rat model.
Methods. Sixty-four Wistar albino rats were included in the study. Animals were allocated into 8 groups
(n = 8). After a 70% hepatectomy, liver regeneration, angiogenesis, and antiangiogenic response were
evaluated in the remnant liver on days 0, 1, 2, 3, 5, 7, 10, and 14. Regeneration and angiogenesis were
determined with immunoreactivity to proliferating cell nuclear antigen and vascular endothelial growth
factor. Antiangiogenic response was evaluated by detecting collagen 18 m RNA with reverse transcriptase
polymerase chain reaction.
Results. We showed that liver regeneration peaked at day 1, whereas angiogenesis in the periportal and
perisinusoidal areas reached their peak values on days 3 and 7, respectively. Both regeneration and
angiogenic activity around perisinusoidal hepatocytes returned to basal activity on the day 10.
Antiangiogenic response first appeared on day 5, reached a peak on day 10, and returned to basal values
on day 14.
Conclusion. Collagen18 mRNA expression is present in the normal liver during the regenerative process.
We suggest that the stimulus that causes the cessation of regeneration process may come from hepatocytes,
and collagen 18 produced by hepatocytes may modulate this event by inhibiting the angiogenesis.
(Surgery 2010;147:288-94.)From the Departments of General Surgerya and Pathology,b and Pediatric Allergy and Asthma
Research Laboratory,c Medical School, Hacettepe University, Ankara; Department of Molecular Biology and
Genetics, Bilkent University,d Ankara, TurkeyTHE LIVER is unique in restoration of its anatomic
volume and mass after toxic injury or surgical
resection. Liver responds to these changes by
regeneration.1 The optimal mass that the liver
has to reach after partial hepatectomy or trans-
plantation depends on predetermined parameters
such as liver/body mass ratio.2-4 Time to restore
liver mass depends on liver function rather than
anatomy.1,5-8
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URGERYhepatectomy, first hepatocyte regeneration and
then angiogenesis occur, and the liver reaches its
optimal functional volume and mass between
postoperative days 7 and 10 in rats.2,9-11 Interest-
ingly, liver regeneration does not cause pathologic
angiogenesis or growth out of control. When the
liver reaches its optimal functional size, regenera-
tion stops.10
In 1997, O’Reilly et al identified endostatin,
which is an endogenous angiogenesis inhibitor
produced by hemangioendothelioma. Endostatin
was shown to be identical to the carboxy terminal of
collagen 18. Systemic administration of endostatin
inhibits potently angiogenesis and tumor growth
and maintains metastases at a microscopic size.12
The liver was shown to be the main site of
collagen 18 synthesis, and hepatocytes in the nor-
mal liver and satellite cells in the cirrhotic liver have
been reported to be the important sources of this
type of collagen.13 Collagen 18 is the only type of
collagen known to be synthesized by hepatocytes.14
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and antiangiogenic therapy for many types of solid
neoplasms have been well studied after the discov-
ery of endogenous angiogenesis inhibitors, to the
best of our knowledge, no study in the literature
has demonstrated antiangiogenic activity of the
liver during normal liver regeneration. Most of the
studies have focused on dependence of liver re-
generation on angiogenesis.10,15-17
The aim of this study was to evaluate the
antiangiogenic activity of the liver and its relation
to regeneration and angiogenesis after 70% hep-
atectomy in rats.
MATERIALS AND METHODS
A total of 64 adult female Wistar albino rats
weighing 250--350 g used in the study were fed with
standard diet and water ad libitum and kept under
standard room temperature at 22--24C and in a
12-hr light/dark cycle. Animals were fasted for 8 hr
before hepatectomy. The Institutional Committee
of Ethics of Animal Experiments at Hacettepe
University approved the study in accordance of
Declaration of Helsinki and institutional guide for
use of laboratory animals (2005/72-5).
Experimental design. Sixty-four female rats were
divided randomly into 8 groups of 8 rats each.
Seventy percent hepatectomy was performed un-
der 5 mg/kg xylazine (Rompun Bayer, Turkey) and
30 mg/kg ketamine hydrocloride (Ketalar Panker
Davis, Turkey) anesthesia according to the method
described by Higgins and Anderson.18 Groups
were numbered according to day that the rats
were sacrificed. After the 70% hepatectomy ani-
mals were sacrificed on days 0, 1, 2, 3, 5, 7, 10,
and 14 respectively. All groups were operated on
during the same period during the light-dark cycle.
Regenerating remnant livers were removed and
specimens were fixed in 10% formalin solution
for immunohistochemistry; a portion of liver was
kept at --80C for reverse transcriptase polymerase
chain reaction examination (RT-PCR).
Regenerative and angiogenetic activity of the
remnant liver was evaluated by immunohistochem-
istry for proliferating cell nuclear antigen (PCNA)
and vascular endothelial growth factor (VEGF).
Regenerating livers were fixed in 10% formalin
overnight and then embedded in paraffin blocks.
Sections from the widest surface of the liver, each 4
mm thick, were cut. Antiangiogenetic activity was
evaluated by RT-PCR technique for collagen 18; no
good antibody was available for Western blot, Eliza,
or immunohistochemistry for collagen 18 protein.
PCNA immunohistochemistry. PCNA (Neo-
Markers; Cat. #MS-106-P; LabVision Corp., Fremont,CA) staining was performed on formalin-fixed,
paraffin-embedded, 4-mm thick sections using stan-
dard staining procedures. After deparaffinization
and antigen retrieval with boiling in citrate buffer
(pH6), the sections were incubated with primary
antibody according to the manufacturer’s instruc-
tions and then processed by biotinylated goat
anti-mouse antibodies followed by streptavidin con-
jugated to horseradish peroxidase (Polyvalent Ultra-
Tek Lab Pack Kit; ScyTek Laboratories Inc., Logan,
UT) with the use of diaminobenzidine as the chro-
mogen (DakoCytomation, Glostrup, Denmark).
Nuclei stained in brown were considered as positive
for PCNA. The PCNA labeling index was calculated
as proportion of PCNA-positive hepatocytes per
1000 hepatocytes counted under a light microscope
at 40 3 magnification.
VEGF immunohistochemistry. Immunohisto-
chemical staining for VEGF on formalin-fixed
and paraffin-embedded, 4-mm thick, sections, was
performed with anti-VEGF antibody (NeoMarkers
VEGF Ab-1, Cat. #RB-222-R7). After deparaffiniza-
tion and antigen retrieval with boiling in citrate
buffer (pH 6), the sections were incubated with
primary antibody according to the manufacturer’s
instructions and then processed by biotinylated
goat anti-mouse antibodies followed by streptavi-
din conjugated to horseradish peroxidase (Polyva-
lent UltraTek Lab Pack Kit; ScyTek Laboratories)
with the use of diaminobenzidine as the chromo-
gen (DakoCytomation). Slides were examined by
two blinded pathologists. VEGF staining was en-
countered mainly in periportal and perisinusoidal
areas, and a semiquantitative analysis for VEGF
staining was performed according to the degree of
VEGF positive cell layer around these areas. Ac-
cordingly, VEGF staining in periportal areas was
classified into 4 groups: 0, no staining; 1+, only one
layer of VEGF positive hepatocytes around portal
triad; 2+, 2 cell layer thickness of VEGF positive
cells; and 3+, equal to or more than 3 layers of
hepatocytes positive for VEGF around portal areas.
Perisinusoidal staining of VEGF was assessed as
follows: 0, no staining; 1+, VEGF positivity in
<25% of perisinusoidal hepatocytes; 2+, VEGF pos-
itivity in 25--50% of perisinusoidal hepatocytes; 3+,
VEGF expression in majortity of perisinusoidal
hepatocytes, including pericentral areas.
Determination of anti-angiogenetic activity. Col-
lagen 18 messenger ribonucleic acid (mRNA) was
analyzed with RT-PCR to determine the anti-angio-
genic activity in the regenerating liver after 70%
hepatectomy. Total RNA was extracted from tissue
samples with RNeasy mini kit (RNAaz, QIAGEN,
Valencia, CA) according to the instructions of the
Table. Sequence of primers used in PCR reactions and product sizes and annealing temperatures
Primary sequences PCR PRODUCT size (bp) Annealing temperature (C)
Rat B-actin F 5’-TTGTAACCAACTGGGACGATATGG-3’
Rat B-actin R 5’-GATCTTGATCTTCATGGTGCTAGG-3’
764 58
Rat GAPDH F 5’-AATGCATCCTGCACCACCAA-3’
Rat GAPDH R 5’-GTAGCCATATTCATTGTCATA-3’
500 56
Rat Col18 F 5’-GGCGAGCAGATGACATCTT-3’
Rat Col18 R 5’-CGCCGGAGAACAGGGTGT-3’
413 58
Fig 1. PCNA labeling index of hepatocytes reached its
peak value on the first day. It remained high for 7 days
compared to its basal value and returned to its basal
value on day 10.
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with pestle in RNA liquid nitrogen and lysed by
using RNA lysis buffer. Homogenized lysate was
loaded onto RNeasy spin column and centrifuged.
After washing steps, total RNA was dissolved in
RNAse free water. RNA amounts were measured at
260 and 280 nm in UV spectrophotometer. Total
RNA (1000 ng) was reverse-transcribed at 42C for
1 hr using ImProm-II Reverse Transcription Sys-
tem from Promega (Madison, WI). Polymerase
chain reaction reactions with rat b-actin primers
and glyceraldehyde 3-phospho dehydrogenase
(GAPDH) were used to confirm the presence of
equal amount of cDNA for each reactions. After
equalization of samples using the housekeeping
genes b-actin and GAPDH, collagen 18 gene was
amplified with Taq polymerase (Promega) at final
concentration of 1.5 mM MgCl2. Sequence of
primers used in PCR reactions, product sizes, and
annealing temperatures are listed in the Table.
PCR fragments were then subjected to electropho-
resis on a 1.5% agarose gel containing ethidium
bromide, visualized by ultraviolet transillumination,
and captured by imaging system. The blots were
obtained in all rats.Quantification of RT-PCR results. Quantifica-
tion of RT-PCR results was performed by the
Bio-Profil V99 (Chemi-Capt 2000 Version 12.8,
Bio-Profil Bio-1D Version 11.9; Vilber Lourmat,
Marne la Vallée, France) analyzer program. Back-
ground activity on the ultraviolet images were
ignored. Color density of the bands were calculated
by the program and the ratio of C18 band color
density to corresponding b-actin or GAPDH color
density was calculated.
Statistical analysis. The comparisons of statisti-
cal significance among groups were performed
with the Kruskal-Wallis and the Mann-Whitney U
test between independent groups. The day on
which P < .05 for the first time was considered as
a significant increase and the day on which P > .1
was considered as returning to basal activity. Con-
tinuous variables are presented as median values
with interquartile ranges (boxes) and ranges.
RESULTS
Liver regeneration after 70% hepatectomy.
PCNA labeling index was less than 5% in hepato-
cytes on day 0. A dramatic increase in the PCNA
labeling index of hepatocytes were observed on
day 1 which was its peak value (P = .003). This in-
dex gradually decreased but remained significantly
greater than basal values until day 7. On day 10,
the PCNA labeling index of hepatocytes reached
its basal value and remained low until day 14
(P = .143; Figs 1 and 2).
Angiogenic activity of the remnant liver. Angio-
genic activity in periportal hepatocytes: There were very
few VEGF-positive hepatocytes on day 1. The
increased expession of VEGF on day 0 was attrib-
uted to operative trauma caused by the hepatec-
tomy. When compared with day 1, expression of
VEGF on periportal hepatocytes peaked on day 3
(P = .001) and decreased to the basal value on day
5 and day 7 was not significant when compared
with day 1 (Figs 3 and 4).
Angiogenic activity in perisinusoidal hepatocytes:
There were very few VEGF-positive hepatocytes
on day 1. The increased expession of VEGF on
day 0 was attributed to operative trauma caused by
Fig 2. (A) Immunohistochemical staining for PCNA . On the first day after 70% hepatectomy more than 90% of hepa-
tocytes were positive for PCNA. (B) On the tenth day less than 5% of hepatocytes were positive for PCNA.
Fig 3. VEGF immunoreactivity in periportal hepatocytes
reached its peak value on day 3 and returned to its basal
value on day 5.
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soidal hepatocytes began on day 3, gradually
increased and reached its peak value on day 7
(P = .039) and returned to its basal value on day 10
compared to day 1. Changes on day 3 and 5 were
not statistically significant (Fig 4 and 5).
Antiangiogenic activity of the remnant liver after
70% hepatectomy. Anti-angiogenic activity of the
liver after 70% hepatectomy was first detected on
day 3. The first significant increase occurred on
day 5 (P = .011) and reached its peak value on day
10 (P = .001) and returned to basal value on day 14
(P = .34; Figs 6 and 7).
DISCUSSION
In this study, we showed that antiangiogenic
activity in the remnant liver was seen initially on
day 3, and a significant increase was noted on day 5
after 70% hepatectomy. On day 5, the angiogenicactivity declined around periportal hepatocytes
and started to increase around the perisinusoidal
hepatocytes. In contrast, peak antiangiogenic ac-
tivity was detected on day 10, corresponding to the
return of angiogenic activity to basal values around
perisinusoidal hepatocytes and the day on which
the liver reached its optimal functional volume
(day 7--10).1,2
Previously, it has been shown that when angio-
genic agents are administered, liver regeneration
increases by 16--42%.10 In contrast, when antian-
giogenic agents are administered, liver regenera-
tion decreases by 46--74%.10,17 These findings
support the idea of dependence of liver regenera-
tion on angiogenesis. While angiogenic agents in-
crease liver regeneration in the early days of liver
regeneration (42% on day 2 and 16% on day 8),
the most pronounced effects of antiangiogenic
agents on liver regeneration appear in the later
days of regeneration (decreases regeneration on
days 2 and 8 by 46% and 64%, respectively, and
50% on day 7).10,17 These late, negative effects of
antiangiogenic agents on regeneration may be ex-
plained by appearance of angiogenesis later than
regeneration after partial hepatectomy. However,
endogenous antiangiogenic activity during normal
liver regeneration after partial hepatectomy has
not been shown.
Peak values of regeneration and angiogenesis
were detected on days 1 and 3, respectively, in this
study. There was a 48-hr delay between regeneration
and angiogenesis that can be explained by inde-
pendence of regeneration from angiogenesis at an
early time of regeneration. At a later stage, regen-
eration may become dependent on angiogenesis.
Angiogenesis is stimulated by angiogenic factors
such as VEGF and fibroblast growth factor (FGF)
which are expressed by regenerating hepatocytes.
Fig 4. Representative sections of rat livers showing VEGF distribution (arrowheads, portal areas; asterisks, central veins)
within day 0 and 14 (all figures; 200 3): (A) 1 + VEGF expression in both periportal and pericentral/sinusoidal areas.
(B, C) Second and third days with minimal VEGF activity. (D) 2--3 layers of VEGF positive hepatocytes (3+) around por-
tal vein, comparing to 1+ expression in pericentral and sinusoidal areas. (E) transposition of VEGF activity from peri-
portal areas (1+) to pericentral areas (3+) on day 5. (F) VEGF activity in periportal areas ceased. Note the continuing
activity around central vein. (G, H) VEGF expression diminished in rat liver after day 10 of partial hepatectomy.
Fig 5. VEGF immunoreactivity in perisinusoidal hepato-
cytes increased on day 3 but reached peak value on day 7
and returned to basal value on day 10.
Fig 6. Transcript levels of mRNA for collagen 18 normal-
ized to GAPDH or actin reached peak value on day 10
and returned to basal value on day 14.
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angiogenesis and regeneration has been also shown
in other models of 70% hepatectomy.16,19,20
Although it is well known that many factors,
such as hepatocyte growth factor, epidermal
growth factor, and transforming growth factor
alpha, trigger hepatocyte proliferation after partial
hepatectomy, it is not well known which factor (orfactors) eventually stops the liver regeneration
after the liver reaches its optimal mass. Some
studies have focused on TGF-b1, a known inhibitor
of proliferation in hepatocyte cultures2; however,
hepatocyte proliferation stops between 48 and 72
hr, a time when they are still resistant to TGF-b1.
Therefore, TGF-b1 is not sufficient to act as the ter-
minating signal for liver regeneration.2
Fig 7. A sample from ultraviolet images obtained by
RT-PCR of each animal was compared with correspond-
ing b-actin or GAPDH.
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agents modulate the liver regeneration of hepatic
mass primarily by affecting endothelial cell prolif-
eration or apoptosis.10 They hypothesized that en-
dothelial cells may be the physiologic brake that
stops liver regeneration based on the finding that
endothelial apoptosis increased on the same day
that the liver reached its pre-operative volume.10
From these findings, they suggested that endothe-
lial cells were a key mediator of regenerating adult
tissue mass in a partial hepatectomy model.10 Al-
though they evaluated the effect of exogenously
applied endothelial cell specific agents on hepatic
regeneration, they did not study endogenous
agents.
In our study, we demonstrated that expression
of mRNA for collagen 18 was present during liver
regeneration after partial hepatectomy, indicative
of antiangiogenic activity of hepatocytes. This is
the first study to demonstrate antiangiogenic ac-
tivity during normal liver regeneration in the
remnant liver after partial hepatectomy in rats.
We used C18 as a marker of antiangiogenic activity,
because it is the precursor molecule of endostatin
(22 kDa), which is known to be an endogenous
antiangiogenic agent.21,22 Oh et al isolated a col-
lagenous polypeptide and designated it as C18.14
In addition, they showed that C18 was present in
multiple organs with the greatest level in the liver,
lungs, and kidney.14 Later, the liver was shown to
be the main site of C18 synthesis, and hepatocytes
in the normal liver and satellite cells in thecirrhotic liver were reported to be the important
sources of this type of collagen.13 C18 expression
is increased in some conditions such as hepatocel-
lular carcinoma and liver fibrosis. As a result, it has
been postulated that the precursor of endostatin
might be expressed differently according to the
differentiated and/or transformed state of hepato-
cytes.13,23,24 According to the findings of the pre-
sent study, we suggest that there is baseline
synthesis of C18 in hepatocyes (0.5 on day 0),
but that its expression is increased during liver
regeneration.
Sasaki et al demonstrated the broad occurrence
of endostatin-like proteins in tissues and serum
with size ranges of 22 kDa to 38 kDa. In fact, they
showed that the noncollagenous domain (NC1) of
C18 had 11 different positions in the hinge region
sensitive to proteolysis. This structure may indicate
that several different proteolytic pathways may
exist for the generation of endostatin in tissues.25
Immunohistochemical studies have shown that
molecules derived from C18 in tissues resemble
NC1, whereas in circulation they are more similar
to endostatin.26 Also, it has been demonstrated
that NC1 is released from parental collagen in
many tissues, and that a second proteolytic step
may be required to release soluble endostatin
which could act in a paracrine or endocrine
fashion.25
In another study, serum endostatin levels were
greater on day 14 compared to day 1 after 40% and
70% hepatectomy in normal mice5; angiogenesis
disappeared, however, on day 7. This high level
of endostatin after cessation of angiogenesis was as-
cribed to the prolonged effect of endostatin.5 In
contrast, we found that C18 mRNA expression in
hepatocytes peaked on day 10, but returned to ba-
sal values on day 14. This difference between the
changes in serum endostatin levels and tissue
C18 mRNA expression may be explained by the
fact that C18 shows its antiangiogenic effect during
liver regeneration in a paracrine fashion, but endo-
statin, of which C18 is the precursor molecule, may
continue to be present in circulation for its endo-
crine function. Further studies are needed to de-
termine tissue expression of C18 protein and
serum endostatin levels during liver regeneration.
In conclusion, we demonstrated that C18
mRNA expression is present in the normal liver
during the regenerative process. The stimulus that
causes the cessation of the regeneration process
may come from hepatocytes and collagen 18 pro-
duced by hepatocytes may modulate this event by
inhibiting angiogenesis. The production of C18
protein and its functional activity during normal
Surgery
February 2010
294 Dogrul et alliver regeneration need to be demonstrated in
further studies.
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